Nox2-derived oxidative stress may contribute to myocardial injury via production of ROS, and thus inhibition of Nox2 may have therapeutic potential for COVID-19.211 Alteration in RAS after SARS-CoV-2 infection could predispose bradykinin storm. Here, CYBB is linked to COVID-19.